| Phase 1 | 2 | |
| Phase 2 | 1 |
| NCT ID | Title | Condition | Status | Updated |
|---|---|---|---|---|
| Phase 2 | ||||
| NCT07518979 | EGFR-ADC (Becotatug Vedotin) Combined With PD-1 Inhibitor (Pucotenlimab) in Neoadjuvant… | Penile Cancer | Recruiting | 2026-07-29 |
| Phase 1 | ||||
| NCT07051187 | A Trial to Evaluate the Efficacy and Safety of WGc0201 in Patients With Chronic Hepatitis… | Chronic Hepatitis B Virus (Hbv) | Recruiting | 2026-07-01 |
| NCT07054307 | MRG003 Plus HX008 as First-Line Treatment for EGFR-Positive Locally Advanced or… | Penile Cancer | Recruiting | 2026-04-07 |